Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.1117 | 0.7026 | 0.8938 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.1117 | 0.7026 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.1428 | 1 | 0.5 |
Onchocerca volvulus | 0.1205 | 0.7861 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.1205 | 0.7861 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.1117 | 0.7026 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1117 | 0.7026 | 0.8938 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.1133 | 0.7174 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.1205 | 0.7861 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.1117 | 0.7026 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 40 uM | Inhibition of human recombinant DNA polymerase beta | ChEMBL. | 23968551 |
IC50 (ADMET) | > 40 uM | Cytotoxicity against TdT-deficient human HeLa cells assessed as growth inhibition after 24 to 48 hrs by MTT assay | ChEMBL. | 23968551 |
ID50 (binding) | = 0.58 uM | Inhibition of human recombinant TdT using [3H]dNTP as substrate after 10 mins by scintillation counting analysis | ChEMBL. | 23968551 |
ID50 (binding) | = 40 uM | Inhibition of human recombinant full length DNA polymerase lambda TdT-like activity using [3H]dNTP as substrate after 10 mins by scintillation counting analysis | ChEMBL. | 23968551 |
ID50 (binding) | > 40 uM | Inhibition of human recombinant full length DNA polymerase lambda using [3H]dTTP as substrate and 10 poly(dA)/oligo(dT) as template-primer after 15 mins by scintillation counting analysis | ChEMBL. | 23968551 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.